{"id":49316,"date":"2022-10-07T10:01:36","date_gmt":"2022-10-07T08:01:36","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/?p=49316"},"modified":"2022-10-07T14:52:26","modified_gmt":"2022-10-07T12:52:26","slug":"chiesi","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/chiesi\/","title":{"rendered":"Chiesi ranks 10th in Pharma Trend Ranking 2022"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-49261 alignleft\" src=\"https:\/\/pharma-trend.com\/en\/wp-content\/uploads\/sites\/2\/2022\/10\/MRC_G_2022_Top10-300x173.png\" alt=\"\" width=\"300\" height=\"173\" srcset=\"https:\/\/pharma-trend.com\/en\/wp-content\/uploads\/sites\/2\/2022\/10\/MRC_G_2022_Top10-300x173.png 300w, https:\/\/pharma-trend.com\/en\/wp-content\/uploads\/sites\/2\/2022\/10\/MRC_G_2022_Top10-1024x589.png 1024w, https:\/\/pharma-trend.com\/en\/wp-content\/uploads\/sites\/2\/2022\/10\/MRC_G_2022_Top10-768x442.png 768w, https:\/\/pharma-trend.com\/en\/wp-content\/uploads\/sites\/2\/2022\/10\/MRC_G_2022_Top10-1536x884.png 1536w, https:\/\/pharma-trend.com\/en\/wp-content\/uploads\/sites\/2\/2022\/10\/MRC_G_2022_Top10-2048x1179.png 2048w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/>Chiesi is ranked 10th in the multispecialist &#8220;Best Pharmaceutical Companies Germany&#8221; 2022 ranking in the category &#8220;Large individual, medium-sized and international companies&#8221;. Infectopharm, Gedeon Richter, ALK-Abell\u00f3 and Exeltis placed first in this year&#8217;s Pharma Trend study. Chiesi has made a name for itself as a research company, especially in the field of respiratory diseases.<\/p>\n<p><!--more--><\/p>\n<h2>Chiesi: AIR, RARE and CARE<\/h2>\n<p>Chiesi Farmaceutici S.p.A., headquartered in Parma, is a research-based, international pharmaceutical and healthcare company. The Group currently employs 6,440 people in a global organisation that includes 30 subsidiaries, seven research centres in Italy, France, the United States, Canada, China, the United Kingdom and Sweden, three production sites in Italy, France and Brazil, and representative offices in 90 countries.<\/p>\n<p>Chiesi is dedicated to three therapeutic areas: AIR, products and services related to respiratory diseases; RARE, the treatment of patients with rare and very rare diseases; CARE, products and services for specialist care and self-medication.<\/p>\n<p>The Chiesi Group generated revenues of \u20ac2.42 billion in 2021 with strong international growth of 8.6%. Half of these revenues were generated by leading products in the AIR segment. Chiesi developed products mainly for chronic obstructive pulmonary disease (COPD) and bronchial asthma, such as Budiair\u00ae, Forair\u00ae, Foster\u00ae, Inovair\u00ae, Sanasthmax\u00ae and Trimbow\u00ae, including the necessary inhalation and nebulisation systems. The respiratory R&amp;D pipeline was expanded through a partnership with UCB, including the commercialisation of a clinical-stage monoclonal antibody, transglutaminase 2, in fibrosis diseases.<\/p>\n<p>In addition to the core area of respiratory diseases, Chiesi is increasingly involved in neonatology (Curosurf\u00ae for neonatal respiratory distress syndrome), transplantation medicine (Envarsus\u00ae for immunosuppression) and biotechnology (construction of a biotech centre of excellence plant in Parma). A separate business unit, Chiesi Global Rare Diseases, is dedicated to rare diseases (including Ferriprox\u00ae for iron overload, Raxone\u00ae for optic neuropathy); it generates about 11% of total sales.<\/p>\n<p>Chiesi&#8217;s Research and Development Centre in Parma employs 361 people. Expenditure on research and development amounted to 478.8 million euros in 2021, i.e. just under 20% of turnover.<\/p>\n<p>The German subsidiary, Chiesi GmbH, based in Hamburg, employs around 375 people. As the second-largest sales company in the Chiesi Group, it generated sales of 308.7 million euros in 2021.<\/p>\n<p>Chiesi Farmaceutici S.p.A. has been recognised as a Top Employer\u00ae in eight countries worldwide: Italy, Brazil, Germany, Greece, Poland, Russia, the UK and the USA. More than 54 per cent of employees worldwide are female and almost two-thirds work in research and development.<\/p>\n<div id=\"accordion-1\" class=\"accordion no-js\">\n\t\t\t\t\t<div role=\"button\" id=\"accordion-1-t1\" class=\"accordion-title js-accordion-controller\" aria-controls=\"accordion-1-c1\" aria-expanded=\"false\" tabindex=\"0\" data-initialstate=\"closed\">\n\t\t\t\tAbout the award ceremony\t\t\t<\/div>\n\t\t\n\t\t<div id=\"accordion-1-c1\" class=\"accordion-content\" aria-hidden=\"true\">\n\t\t\t<\/p>\n<p>The awards were announced on 13 September 2022 at the Deutsches Museum in Munich. The keynote speech was given by the patron of the event, the Bavarian Minister of Health Klaus Holetschek, Bavarian State Ministry of Health and Care. The festive awards ceremony was hosted by TV presenter Tamara Sedmak (Sat 1, n-tv, N24).<\/p>\n<p>\t\t<\/div>\n\n\t\t<\/p>\n<p>\n\t\t\t\t\t<div role=\"button\" id=\"accordion-1-t2\" class=\"accordion-title js-accordion-controller\" aria-controls=\"accordion-1-c2\" aria-expanded=\"false\" tabindex=\"0\" data-initialstate=\"closed\">\n\t\t\t\tPharma Trend - The market research on innovation and sustainability\t\t\t<\/div>\n\t\t\n\t\t<div id=\"accordion-1-c2\" class=\"accordion-content\" aria-hidden=\"true\">\n\t\t\t<\/p>\n<p>The basis for the ranking and the awards is the Pharma Trend benchmark study, which has been conducted annually in the Rx category among physicians in Germany since 2000 and since 2018 also in the OTC and Orphan Drugs categories, and since 2019 also in the Specialty Care category on behalf of the PharmaBarometer magazine (<a href=\"https:\/\/pharmabarometer.de\/pharmabarometer\/\">https:\/\/pharmabarometer.de\/pharmabarometer\/<\/a>). In 2021, the study was expanded to include the categories &#8220;Diagnostics&#8221; and &#8220;Digital Health Applications&#8221;. With the expansion of Pharma Trend, companies in pharmaceuticals and medical technology are assessed on innovation and sustainability via their most important stakeholders &#8211; doctors, pharmacists and patients. This year, Pharma Trend was conducted online with 700 physicians, including allergists, general practitioners, dermatologists, gynaecologists, oncologists\/haematologists, paediatricians and urologists, as well as 100 pharmacists and 600 patients.<\/p>\n<p>Further information on Pharma Trend and the report volumes at <a href=\"https:\/\/pharma-trend.com\/en\/\">https:\/\/pharma-trend.com\/en\/<\/a><\/p>\n<p>\t\t<\/div>\n\n\t\t<\/p>\n<p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Chiesi is ranked 10th in the multispecialist &#8220;Best Pharmaceutical Companies Germany&#8221; 2022 ranking in the category &#8220;Large individual, medium-sized and international companies&#8221;. Infectopharm, Gedeon Richter, ALK-Abell\u00f3 and Exeltis placed first in this year&#8217;s Pharma Trend study. Chiesi has made a name for itself as a research company, especially in the field of respiratory diseases.<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[30],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-redaktion","4":"has-more-link","5":"post-49316","7":"format-standard","8":"category-allgemein","9":"post_tag-ranking"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Chiesi ranks 10th in the Pharma Trend Ranking 2022<\/title>\n<meta name=\"description\" content=\"Chiesi ranks 10th in the current Pharma Trend Ranking 2022 \u27a4 Read all about Chiesi at the award ceremony &amp; the ranking 2022 now!\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/chiesi\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Chiesi ranks 10th in the Pharma Trend Ranking 2022\" \/>\n<meta property=\"og:description\" content=\"Chiesi ranks 10th in the current Pharma Trend Ranking 2022 \u27a4 Read all about Chiesi at the award ceremony &amp; the ranking 2022 now!\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/chiesi\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-07T08:01:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-10-07T12:52:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pharma-trend.com\/en\/wp-content\/uploads\/sites\/2\/2022\/10\/MRC_G_2022_Top10-300x173.png\" \/>\n<meta name=\"author\" content=\"Editorial staff\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Editorial staff\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chiesi\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chiesi\\\/\"},\"author\":{\"name\":\"Editorial staff\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/53680e07d08f15177cbc0c55e270bcbc\"},\"headline\":\"Chiesi ranks 10th in Pharma Trend Ranking 2022\",\"datePublished\":\"2022-10-07T08:01:36+00:00\",\"dateModified\":\"2022-10-07T12:52:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chiesi\\\/\"},\"wordCount\":618,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chiesi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2022\\\/10\\\/MRC_G_2022_Top10-300x173.png\",\"keywords\":[\"Ranking\"],\"articleSection\":[\"Allgemein\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chiesi\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chiesi\\\/\",\"name\":\"Chiesi ranks 10th in the Pharma Trend Ranking 2022\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chiesi\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chiesi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2022\\\/10\\\/MRC_G_2022_Top10-300x173.png\",\"datePublished\":\"2022-10-07T08:01:36+00:00\",\"dateModified\":\"2022-10-07T12:52:26+00:00\",\"description\":\"Chiesi ranks 10th in the current Pharma Trend Ranking 2022 \u27a4 Read all about Chiesi at the award ceremony & the ranking 2022 now!\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chiesi\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chiesi\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chiesi\\\/#primaryimage\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2022\\\/10\\\/MRC_G_2022_Top10.png\",\"contentUrl\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2022\\\/10\\\/MRC_G_2022_Top10.png\",\"width\":2700,\"height\":1554},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chiesi\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Chiesi ranks 10th in Pharma Trend Ranking 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/53680e07d08f15177cbc0c55e270bcbc\",\"name\":\"Editorial staff\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Chiesi ranks 10th in the Pharma Trend Ranking 2022","description":"Chiesi ranks 10th in the current Pharma Trend Ranking 2022 \u27a4 Read all about Chiesi at the award ceremony & the ranking 2022 now!","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/chiesi\/","og_locale":"en_US","og_type":"article","og_title":"Chiesi ranks 10th in the Pharma Trend Ranking 2022","og_description":"Chiesi ranks 10th in the current Pharma Trend Ranking 2022 \u27a4 Read all about Chiesi at the award ceremony & the ranking 2022 now!","og_url":"https:\/\/pharma-trend.com\/en\/chiesi\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-07T08:01:36+00:00","article_modified_time":"2022-10-07T12:52:26+00:00","og_image":[{"url":"https:\/\/pharma-trend.com\/en\/wp-content\/uploads\/sites\/2\/2022\/10\/MRC_G_2022_Top10-300x173.png","type":"","width":"","height":""}],"author":"Editorial staff","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Editorial staff"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/chiesi\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/chiesi\/"},"author":{"name":"Editorial staff","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/53680e07d08f15177cbc0c55e270bcbc"},"headline":"Chiesi ranks 10th in Pharma Trend Ranking 2022","datePublished":"2022-10-07T08:01:36+00:00","dateModified":"2022-10-07T12:52:26+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/chiesi\/"},"wordCount":618,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/chiesi\/#primaryimage"},"thumbnailUrl":"https:\/\/pharma-trend.com\/en\/wp-content\/uploads\/sites\/2\/2022\/10\/MRC_G_2022_Top10-300x173.png","keywords":["Ranking"],"articleSection":["Allgemein"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/chiesi\/","url":"https:\/\/pharma-trend.com\/en\/chiesi\/","name":"Chiesi ranks 10th in the Pharma Trend Ranking 2022","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/chiesi\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/chiesi\/#primaryimage"},"thumbnailUrl":"https:\/\/pharma-trend.com\/en\/wp-content\/uploads\/sites\/2\/2022\/10\/MRC_G_2022_Top10-300x173.png","datePublished":"2022-10-07T08:01:36+00:00","dateModified":"2022-10-07T12:52:26+00:00","description":"Chiesi ranks 10th in the current Pharma Trend Ranking 2022 \u27a4 Read all about Chiesi at the award ceremony & the ranking 2022 now!","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/chiesi\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/chiesi\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/chiesi\/#primaryimage","url":"https:\/\/pharma-trend.com\/en\/wp-content\/uploads\/sites\/2\/2022\/10\/MRC_G_2022_Top10.png","contentUrl":"https:\/\/pharma-trend.com\/en\/wp-content\/uploads\/sites\/2\/2022\/10\/MRC_G_2022_Top10.png","width":2700,"height":1554},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/chiesi\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Chiesi ranks 10th in Pharma Trend Ranking 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/53680e07d08f15177cbc0c55e270bcbc","name":"Editorial staff"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49316","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49316"}],"version-history":[{"count":3,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49316\/revisions"}],"predecessor-version":[{"id":49375,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49316\/revisions\/49375"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49316"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49316"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49316"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}